MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
3.320
-0.110
-3.21%
After Hours: 3.320 0 0.00% 16:10 12/18 EST
OPEN
3.450
PREV CLOSE
3.430
HIGH
3.500
LOW
3.310
VOLUME
419.19K
TURNOVER
--
52 WEEK HIGH
4.200
52 WEEK LOW
1.325
MARKET CAP
103.05M
P/E (TTM)
-11.3311
1D
5D
1M
3M
1Y
5Y
1D
Fortress Biotech Amends Credit Agreement with Oaktree
TipRanks · 3d ago
Fortress Biotech Announces Unregistered Sale of Warrants in Private Placement
Reuters · 3d ago
Optimistic Buy Rating for Fortress Biotech Driven by Promising CUTX-101 Prospects and FDA Engagement
TipRanks · 3d ago
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
Dow Jones · 3d ago
Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
TipRanks · 3d ago
Cyprium Therapeutics Gains FDA Acceptance for CUTX-101 NDA Resubmission
Reuters · 3d ago
FDA Accepts Fortress Biotech and Cyprium Therapeutics CUTX-101 NDA Resubmission
Reuters · 3d ago
FORTRESS BIOTECH INC - PDUFA TARGET DATE FOR CUTX-101 SET FOR JANUARY 14, 2026
Reuters · 3d ago
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.